Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Sun Pharma Advanced Research Company

BSE: 532872|NSE: SPARC|ISIN: INE232I01014|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 25, 16:00
324.45
-0.75 (-0.23%)
VOLUME 55,831
LIVE
NSE
Apr 25, 15:56
324.15
-1 (-0.31%)
VOLUME 191,620
Announcements on Sun Pharma Adv

20th-Apr-2017 14:36Source: BSE

Sun Pharma Adv- Compliance Certificate For The Half Year Ended 31St March 2017

Pursuant to the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and elec...

19th-Apr-2017 10:50Source: BSE

Sun Pharma Adv- Shareholding for the Period Ended March 31, 2017

Sun Pharma Advanced Research Company Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly

18th-Apr-2017 20:08Source: BSE

Sun Pharma Adv- Compliance Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

As per the requirements of Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith the Compliance Certificate dated 18th April 2016 issue...

17th-Apr-2017 19:50Source: BSE

Sun Pharma Adv- Statement Of Investor Complaints For The Quarter Ended 31St March 2017

Particulars of Complaints during the quarter ended 31st March 2017 Investor complaints pending at the beginning of the quarter - NIL Investor complaints received during the quarter - NIL Investor...

7th-Apr-2017 09:06Source: BSE

Sun Pharma Adv- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sanghvi Finance Pvt Ltd

31st-Mar-2017 19:38Source: BSE

Sun Pharma Adv- Updates

The Company has received an intimation from Shanghvi Finance Pvt. Ltd., a Promoter Group Company, stating that pursuant to an internal restructuring of entities owned / controlled by Mr. Dilip Shanghv...

23rd-Mar-2017 14:26Source: NSE

Sun Pharma Advanced Research Company Limited

Shanghvi Finance Private Limited has submitted to the Exchange, vide its letter dated March 22, 2017 a copy of disclosures under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of...

23rd-Mar-2017 08:57Source: BSE

Sun Pharma Adv- Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shang...

27th-Feb-2017 08:41Source: NSE

Sun Pharma Advanced Research Company Limited

Sun Pharma Advanced Research Company Limited has informed the Exchange that the Company is receipt of a Demand Notice under section 156 of the Income Tax, 1961 demanding the payment by the Company of ...

24th-Feb-2017 19:06Source: BSE

Sun Pharma Adv- Receipt of demand notice under section 156 of the Income Tax Act, 1961

Sun Pharma Advanced Research Company Ltd has informed BSE that the Company is in receipt of a ''Demand Notice'' under section 156 of the Income Tax, 1961 demanding the payment by the Company of a sum ...

1 2 3 4 5 Next >>
Quick Links for Sun Pharma Advanced Research Company
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.